Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Alemtuzumab induction and belatacept maintenance in marginal pathology renal allografts.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Alemtuzumab induction and belatacept maintenance in marginal pathology renal allografts.
Alemtuzumab induction and belatacept maintenance in marginal pathology renal allografts. Clin Transplant. 2019 06; 33(6):e13531.
View in:
PubMed
subject areas
Abatacept
Alemtuzumab
Antineoplastic Agents, Immunological
Female
Follow-Up Studies
Glomerular Filtration Rate
Graft Rejection
Graft Survival
Humans
Immunosuppressive Agents
Induction Chemotherapy
Kidney Failure, Chronic
Kidney Function Tests
Kidney Transplantation
Maintenance Chemotherapy
Male
Middle Aged
Pilot Projects
Postoperative Complications
Prognosis
Prospective Studies
Risk Factors
Transplantation, Homologous
authors with profiles
Rolf Barth